Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Arruda

Showing results (151-160 of 185) with videos related to

Pageof 19
Sort By:
Experimental & Applied Acarology|December 4, 2019
Effects of leaf extracts of Protium spruceanum against adult and larval Rhipicephalus microplusJ C G Figueiredo, Y R F Nunes, Viviane de Oliveira Vasconcelos, et al.
Oncology Letters|June 28, 2016
Hypoxia regulates the expression of tissue factor pathway signaling elements in a rat glioma modelRobson Q Monteiro, Luize G Lima, Nathália P Gonçalves, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 18, 2010
Efficacy and safety of long-term prophylaxis in severe hemophilia A dogs following liver gene therapy using AAV vectorsDenise E Sabatino, Amy M Lange, Ekaterina S Altynova, et al.
Molecular Therapy. Methods & Clinical Development|February 20, 2024
AAV gene therapy in companion dogs with severe hemophilia: Real-world long-term data on immunogenicity, efficacy, and quality of lifeBhavya S Doshi, Benjamin J Samelson-Jones, Timothy C Nichols, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 1, 2010
Prevention of spontaneous bleeding in dogs with haemophilia A and haemophilia BT C Nichols, R A Raymer, H W G Franck, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 10, 2000
Role of vector in activation of T cell subsets in immune responses against the secreted transgene product factor IXP A Fields, D W Kowalczyk, V R Arruda, et al.
Blood|November 26, 2010
Assessing the potential for AAV vector genotoxicity in a murine modelHojun Li, Nirav Malani, Shari R Hamilton, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 11, 2006
Evidence of multiyear factor IX expression by AAV-mediated gene transfer to skeletal muscle in an individual with severe hemophilia BHaiyan Jiang, Glenn F Pierce, Margareth C Ozelo, et al.
Blood|April 4, 2002
Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapyJane D Mount, Roland W Herzog, D Michael Tillson, et al.
Blood|January 3, 2001
Posttranslational modifications of recombinant myotube-synthesized human factor IXV R Arruda, J N Hagstrom, J Deitch, et al.
Pageof 19

Showing results (151-160 of 185) with videos related to

Sort By:
Pageof 19
Experimental & Applied Acarology|December 4, 2019
Effects of leaf extracts of Protium spruceanum against adult and larval Rhipicephalus microplusJ C G Figueiredo, Y R F Nunes, Viviane de Oliveira Vasconcelos, et al.
Oncology Letters|June 28, 2016
Hypoxia regulates the expression of tissue factor pathway signaling elements in a rat glioma modelRobson Q Monteiro, Luize G Lima, Nathália P Gonçalves, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 18, 2010
Efficacy and safety of long-term prophylaxis in severe hemophilia A dogs following liver gene therapy using AAV vectorsDenise E Sabatino, Amy M Lange, Ekaterina S Altynova, et al.
Molecular Therapy. Methods & Clinical Development|February 20, 2024
AAV gene therapy in companion dogs with severe hemophilia: Real-world long-term data on immunogenicity, efficacy, and quality of lifeBhavya S Doshi, Benjamin J Samelson-Jones, Timothy C Nichols, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 1, 2010
Prevention of spontaneous bleeding in dogs with haemophilia A and haemophilia BT C Nichols, R A Raymer, H W G Franck, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 10, 2000
Role of vector in activation of T cell subsets in immune responses against the secreted transgene product factor IXP A Fields, D W Kowalczyk, V R Arruda, et al.
Blood|November 26, 2010
Assessing the potential for AAV vector genotoxicity in a murine modelHojun Li, Nirav Malani, Shari R Hamilton, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 11, 2006
Evidence of multiyear factor IX expression by AAV-mediated gene transfer to skeletal muscle in an individual with severe hemophilia BHaiyan Jiang, Glenn F Pierce, Margareth C Ozelo, et al.
Blood|April 4, 2002
Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapyJane D Mount, Roland W Herzog, D Michael Tillson, et al.
Blood|January 3, 2001
Posttranslational modifications of recombinant myotube-synthesized human factor IXV R Arruda, J N Hagstrom, J Deitch, et al.
Pageof 19